Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06053255 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Use of the Neurolyser XR for the Treatment of Low Back Pain Related to Sacroiliitis

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 22, 2025 (before its estimated September 15, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Primary completion date: Sep 15, 2024 to Sep 15, 2026
    • Start date changed from estimate of Nov 15, 2023 to Sep 13, 2024
    • Study sites: 0 to 1
    • Study completion date: Dec 15, 2024 to Dec 15, 2026
  2. Start date: Sep 15, 2023 to Nov 15, 2023
    • Eligibility criteria expanded, about 12 words
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
FUSMobile Inc.
2 trials monitored
See 1 trial at risk
The Neurolyser XR is a device used to deliver high-intensity focused ultrasound for the ablation of the lateral sacral branch nerve in patients with Sacroiliitis.
Trial Details
NCT Number NCT06053255
Lead Sponsor FUSMobile Inc.
Collaborators: Focused Ultrasound Foundation
Conditions
(from sponsor)		 Sacroiliitis
Related terms Sacroiliitis
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov